Javanbakht M, Khan L, Mustanski B, Shoptaw S, Baum MK, Mehta SH, Kirk GD, Lai S, Moore R, Milloy MJ, Kipke M, Hayashi K, DeBeck K, Siminski S, White LM, Gorbach P Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: findings from the C3PNO Consortium Prev Med Rep, 2023. Link


Argento E, Omene E, Jaeger AH, Kertes A, Mitchell KA, Necyk C, Thielking P, Lewis EC Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy Front Neurosci, 2023. PubMed


Capler NR, Balneaves LG, Buxton JA, Kerr T Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada J Cannabis Res, 2023. PubMed


Weaver VK, Ickowicz S, Fairbairn N Management of γ-hydroxybutyrate intoxication and withdrawal CMAJ, 2023. PubMed


van Santen DK, Lodi S, Dietze P, van den Boom W, Hayashi K, Dong H, Cui Z, Maher L, Hickman M, Boyd A, Prins M Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: a pooled analysis of emulated trials Addiction, 2023. PubMed


Swaich A, Richardson L, Cui Z, DeBeck K, Milloy MJ, Kerr T, Hayashi K Experiences of violence during the COVID-19 pandemic among people who use drugs in a Canadian setting: a gender-based cross-sectional study BMC Public Health, 2023. PubMed


Bouck Z, Tricco AC, Rosella LC, Banack HR, Fox MP, Platt RW, Milloy MJ, DeBeck K, Hayashi K, Werb D First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: a longitudinal cohort study of people who inject drugs in Vancouver, Canada Drug Alcohol Depend Rep, 2023. PubMed


Bardwell G, Ivsins A, Mansoor M, Nolan S, Kerr T Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes CMAJ, 2023. PubMed


Pilarinos A, Bingham B, Kwa Y, Joe R, Grant C, Fast D, Buxton J, DeBeck K Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada J Subst Use Addict Treat, 2023. PubMed


Brooks O, Hayashi K, Cui Z, Milloy MJ, Kerr T, Fairbairn N Re-incarceration and associated social, structural and behavioural factors among people who use drugs in an urban Canadian setting Int J Drug Policy, 2023. PubMed


BC Centre on Substance Use
400-1045 Howe St, Vancouver, BC V6Z 2A9

E: [email protected] | T: (778) 945-7616 | F: (604) 428-5183

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2023, BC Centre on Substance Use